As per the research report, the size of the Asia Pacific Vascular Access Devices Market is valued at USD 0.77 billion in 2021 and is expected to reach USD 1.18 billion by 2026 to grow at 8.76% CAGR during the forecast period 2021 to 2026.
A vascular access makes life-saving hemodialysis treatments possible. Hemodialysis is a procedure for patients with kidney failure. It uses a machine to send the patient's blood through a filter, called a dialyzer, outside the body. The access is a surgically created vein used to remove and return blood during hemodialysis.
The Asia Pacific market is projected to display a modest growth during the forecast period, mainly driven by a growing number of patients with chronic diseases, rising geriatric population, rapidly growing medical tourism industry as well as increasing per capita expenditure on healthcare. The peripherally inserted central catheter has developed at a noteworthy pace since its introduction in the market. Moreover, an increase in per capita expenditure on healthcare coupled with the growing medical tourism industry in developing countries further expected to boost market growth.
This research report segmented and sub-segmented into the following categories:
The drug administration segment is estimated to account for the largest share of the market, the growth of drug administration segment is attributed to the high usage of vascular access devices for drug administration for the treatment of infections, cancer, and other diseases. The hospital segment is expected to dominate this market. The large share of this segment can be accredited to the fact that a majority of vascular procedures are performed in hospital settings.
Asia Pacific is expected to witness the highest CAGR in the coming years due to the increasing geriatric population coupled with medical tourism.
The Top companies leading in the APAC Vascular Access Devices Market profiled in the report are Becton Dickinson and Company, C.R.Bard Inc, Smiths Medical, Inc., Teleflex Incorporated, B Braun Melsungen Ag, AngioDynamics, Terumo Corporation, Nipro Medical Corporation, Edwards Lifesciences Corporation, Ameco Medical, Romsons Scientific & Surgical Pvt. Ltd, and Prodimed.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 End Users
5.1.1 Introduction
5.1.2 Hospitals
5.1.3 Clinics and Ambulatory Care Centers
5.1.4 Other End Users
5.1.5 Y-o-Y Growth Analysis, By End Users
5.1.6 Market Attractiveness Analysis, By End Users
5.1.7 Market Share Analysis, By End Users
5.2 Type
5.2.1 Introduction
5.2.2 Peripheral Vascular Access Devices
5.2.2.1 Midline Devices
5.2.2.2 Short Devices
5.2.2.3 Butterfly/Winged Steel Needles
5.2.3 Central Vascular Access Devices
5.2.3.1 Peripherally Inserted Central Catheters (PICC)
5.2.3.2 Tunneled Catheters
5.2.3.3 Non-Tunneleders Catheters
5.2.3.4 Implanted Ports
5.2.4 Accessories
5.2.5 Y-o-Y Growth Analysis, By Type
5.2.6 Market Attractiveness Analysis, By Type
5.2.7 Market Share Analysis, By Type
5.3 Application
5.3.1 Introduction
5.3.2 Drug Administration
5.3.3 Fluid & Nutrition Administration
5.3.4 Blood TransfusionDiagnostics Testing
5.3.5 Y-o-Y Growth Analysis, By Application
5.3.6 Market Attractiveness Analysis, By Application
5.3.7 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By End Users
6.1.3.3 By Type
6.1.3.4 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By End Users
6.1.4.3 By Type
6.1.4.4 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By End Users
6.1.5.3 By Type
6.1.5.4 By Application
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Becton Dickinson and Company
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 C.R.Bard Inc
8.3 Smiths Medical Inc.
8.4 Teleflex Incorporated
8.5 B Braun Melsungen Ag
8.6 AngioDynamics
8.7 Terumo Corporation
8.8 Nipro Medical Corporation
8.9 Edwards Lifesciences Corporation
8.10 Romsons Scientific & Surgical Pvt. Ltd
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
